A Study to Investigate the Effects of Gastric Acid Suppression by Rabeprazole and BMS-986165 on How Fast and Complete The Drug is Absorbed Into the Body of Healthy Participants

Inclusion Criteria * Healthy participant, as determined by medical history, physical examination, ECGs, and clinical laboratory determinations * Body mass index of 18.0 kilogram per meter square (kg/m\^2) to 32.0 kg/m\^2 * Normal renal function at screening as evidenced by an estimated glomerular filtration rate (GFR) greater than (\>) 80 milliliter per minute per 1.732 meter square (mL/min/1.732 m\^2) Exclusion Criteria: * Any major surgery within 4 weeks of study drug administration * Use of any prescription drugs or over-the-counter acid controllers * Positive urine screen for drugs of abuse, alcohol, or cotinine * History of allergy to BMS-986165, rabeprazole, or related compounds Other protocol inclusion/exclusion criteria may apply.